Products for Research Use Only
RegisterLogin

Burixafor (hydrobromide)

CAT: 0804-HY-19867A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-19867A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Burixafor (TG-0054) hydrobromide is a selective, orally active CXCR4 antagonist that effectively blocks the interaction between CXCR4 and its ligand, stromal cell-derived factor SDF-1. Burixafor hydrobromide interferes with the SDF-1/CXCR4 signaling pathway, prompting the release of bone marrow stem cells into the peripheral circulation, exerting immunomodulatory and anti-inflammatory activities. Burixafor hydrobromide can be used in the study of cancer, Intraocular neovascular diseases (such as choroidal neovascularization), myocardial infarction and other diseases, with the potential to mobilize stem cells, improve cardiac function and reduce inflammatory responses[1][2][3].
CAS Number
1191450-19-7
Product Name Alternative
TG-0054 (hydrobromide)
UNSPSC
12352005
Target
CXCR; VEGFR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation; Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Endocrinology; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Burixafor_hydrobromide.html
Purity
98.0
Solubility
H2O : 50 mg/mL (ultrasonic)
Smiles
NC1=CC(N2CCN(CCP(O)(O)=O)CC2)=NC(NC[C@H]3CC[C@H](CNCCCNC4CCCCC4)CC3)=N1.[H]Br
Molecular Formula
C27H51N8O3P.5/2HBr
Molecular Weight
769.01
References & Citations
[1]Nuñez RE, et al. Microglial Cytokines Induce Invasiveness and Proliferation of Human Glioblastoma through Pyk2 and FAK Activation. Cancers (Basel) . 2021 Dec 7;13 (24) :6160.|[2]Hsu WT, et al. CXCR4 Antagonist TG-0054 Mobilizes Mesenchymal Stem Cells, Attenuates Inflammation, and Preserves Cardiac Systolic Function in a Porcine Model of Myocardial Infarction. Cell Transplant. 2015;24 (7) :1313-28.|[3]Shelke NB, et al. Intravitreal Poly (L-lactide) Microparticles Sustain Retinal and Choroidal Delivery of TG-0054, a Hydrophilic Drug Intended for Neovascular Diseases. Drug Deliv Transl Res. 2011 Feb;1 (1) :76-90.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CXCR4

Related Products

CatalogName
HY-145119AS-01Mindeudesivir (hydrobromide)
HY-A0009-01Galanthamine (hydrobromide)
HY-125971Xylopropamine (hydrobromide)
HY-113843RETRA (hydrobromide)
HY-N2482A-01Guvacine (hydrobromide)
HY-14806A-01Teneligliptin (hydrobromide)
HY-108723Dihydrogalanthamine (hydrobromide)
HY-18200BAtopaxar (hydrobromide)
HY-W206168-01Tetrahydropapaveroline (hydrobromide)
HY-127022AAnisodine (hydrobromide)

Alternative Products

CatalogName
T10635-01Burixafor hydrobromide
T202297-01Burixafor
206522Burixafor HBr
OR1037869-01Carbamimidic bromide hydrobromide (hydrobromide)
GTR19204662-01Tedatioxetine hydrobromide
GTR19203482-01Rociletinib hydrobromide
B3370-5.1Arecoline hydrobromide
B6736-10Citalopram hydrobromide
A3865-5.1Teneligliptin hydrobromide
B6481-50EIT hydrobromide

Popular Products